Molecular typing is predicated on molecular genetic tests and isn't however routinely available. Molecular subtypes and immunohistochemical surrogate markers of your tumors (HR, HER2, triple negative) correlate in about 70%. The differentiation of luminal A and B subtypes by HR position and proliferation markers like Ki-67 can be useful, https://smedleyk420iry7.bmswiki.com/user